In addition, the study found that the level of eukaryotic initiation factor 4A3 (eIF4A3) was significantly related to the expression of ALYREF, and the upregulation of eIF4A3 was prominently correlated with the poor prognosis of HCC patients. Here, EIF4A3 is linked to hepatocellular carcinoma.